National Health (Pharmaceutical Benefits—Early Supply) Specification 2026
9Specification of period relating to a pharmaceutical benefit
Start here
Get a plain-English read of 9
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits—Early Supply) Specification 2026.
9 Specification of period relating to a pharmaceutical benefit
(1) This section is made for paragraph 84AAA(1)(b) of the Act.
(2) For a pharmaceutical benefit that has a listed drug mentioned in an item in Schedule 1 in the form mentioned in that item, and the circumstances identified for section 7 apply, the period specified is the number of days mentioned under the heading ‘Period (days)’ for the item in Schedule 1.
(3) For a pharmaceutical benefit that has a listed drug mentioned in an item in Schedule 2 in the form mentioned in that item, and the circumstances identified for section 8 apply:
(a) if:
(i) the relevant previous supply to the person was made on the basis of a prescription; and
(ii) the quantity or number of units of the pharmaceutical benefit directed to be supplied on any one occasion in the prescription was directed for a relevant purpose for the previously supplied pharmaceutical benefit:
the period specified is the number of days mentioned under the heading ‘Period (days)’ for the item in Schedule 2; and
(b) in any other case—the period specified is 20 days.
(4) Despite subsections (2) and (3), if the relevant previous supply of the pharmaceutical benefit was made under a prescriber bag provision, the period specified is zero days.